Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 275Carcinoma, Intraductal, Noninfiltrating 25Breast Carcinoma In Situ 21Neoplasm Metastasis 14Neoplasms 13Breast Neoplasms, Male 12Ovarian Neoplasms 10Inflammatory Breast Neoplasms 7Glioblastoma 6Endometrial Neoplasms 6Prostatic Neoplasms 5Central Nervous System Neoplasms 5Gliosarcoma 4Fallopian Tube Neoplasms 4Breast Cancer Female 4Brain Neoplasms 4Recurrence 3Obesity 3Hot Flashes 3Glioma 3Carcinoma, Ovarian Epithelial 3Carcinoma, Ductal, Breast 3Breast Diseases 3Astrocytoma 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sleep Wake Disorders 2Sarcoma 2Pancreatic Neoplasms 2Oligodendroglioma 2

Interventions

Magnetic Resonance Spectroscopy 4Specimen Handling 2High-Energy Shock Waves 2Biopsy 2perflutren 1olaparib 1exemestane 1entinostat 1abemaciclib 1X-Rays 1Tamoxifen 1Pharmacogenomic Testing 1Nivolumab 1Letrozole 1Ipilimumab 1Gonadotropin-Releasing Hormone 1Fulvestrant 1Fluorodeoxyglucose F18 1Estradiol 1CTLA-4 Antigen 1Blood Specimen Collection 1Anastrozole 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anatomic Stage III Breast Cancer AJCC v8 × Tamoxifen × Clear all
NCT06179303 2026-04-16

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

University of Washington

Phase 2 Recruiting
60 enrolled
Breast

Anatomic Stage III Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡